$13.6 Billion Spent on This ONE DRUG ALONE Last Year

Prescription costs keep spiraling  higher …

(Bob Herman, AXIOS) Humira, the heavily touted anti-inflammatory drug, netted $13.6 billion in gross U.S. sales last year — the most of any brand-name prescription drug.

[According to reports, Humira costs approximately $4,370 per patient per month. The median U.S. household income is $4,919 per month. Editor]

Politicians who say they want to reform healthcare might want to start here.

RELATED: Trump To Issue An Executive Order To Lower Drug Prices

In all, the 20 top-selling drugs combined generated more than $98 billion in gross U.S. sales in 2016.

The growth in pharmaceutical spending continues to be well above inflation, putting many people in a bind when they pick up their medicine at the pharmacy.

QuintilesIMS, a pharmaceutical research firm, collected the data in an annual report.

Peak global revenue for Humira is projected to hit $20 billion before so-called “biosimilar” versions hit the market in 2022 and eat into sales. READ THE FULL STORY AT AXIOS.COM.

* * MORE PRESCRIPTION DRUG NEWS AT HEADLINEHEALTH.COM * *